source
- FDA urges Amgen to withdraw Tavneos after alleging data manipulation by former developerThe FDA has sent a formal letter to Amgen recommending that the company pull its drug Tavneos from the market. The agency says new information shows the original approval filings from ChemoCentryx…
- Eli Lilly partners with AI startup Profluent to develop next-generation gene editorsEli Lilly announced a collaboration with AI-focused biotech Profluent to create advanced gene-editing tools that could insert whole genes into patients. The partnership is intended to move beyond…